PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US Patent 7,712,080. This proceeding, IPR2025-01511, resulted in a discretionary denial of institution, meaning the claims were not addressed on the merits. This status indicates the patent claims remain untested in AIA trials at the PTAB.

IPR2025-01511 — American Airlines, Inc. et al. v. University of California San Diego

• Type: Inter Partes Review
• Filed: 2025-09-22
• Status: Discretionary Denial (The PTAB declined to institute the IPR based on discretionary grounds, without reaching the merits of the invalidity arguments.)
• Judge panel: Not publicly available from the prompt data or immediate search results, as institution was denied.
• Petition grounds: The petition was filed by American Airlines, Inc. et al.. Specific claims challenged, prior art, and statutory bases (§ 102 / § 103 / § 112) are typically detailed in the petition, but are not made public in the given data for a discretionary denial.
• Institution decision: Denied on 2026-02-27. The PTAB issued a Discretionary Denial. Such denials are often based on factors like parallel district court litigation, timing of the petition, or efficiency considerations, rather than the substantive merits of the invalidity challenge.
• Final Written Decision (if issued): No Final Written Decision was issued as the IPR was not instituted.
• Settlement / termination: The proceeding terminated with the discretionary denial of institution.
• Appeal: No appeal to the Federal Circuit regarding the merits of claim invalidity, as no IPR was instituted. An appeal of the discretionary denial itself is possible but not indicated in the provided data.
• Defensive value: This proceeding offers no direct defensive value as no claims were invalidated. The discretionary denial means the patent owner successfully fended off this particular challenge without the claims being substantively reviewed, which could be seen as a minor hardening of the patent.

Strategic summary

All claims of US Patent 7,712,080 remain UNTESTED by AIA trial proceedings at the PTAB. IPR2025-01511, the sole proceeding filed, was dismissed via a discretionary denial and did not result in any claims being invalidated or sustained on the merits. This leaves the full scope of the original claims intact and subject to future challenges or assertions.

Regarding estoppel, since IPR2025-01511 was denied institution on discretionary grounds, the full scope of § 315(e)(2) estoppel, which typically bars petitioners and their privies from raising grounds that were raised or reasonably could have been raised, is less clear-cut than with a full institution and FWD. However, the petitioner, American Airlines, Inc. et al., may face some form of estoppel regarding the specific arguments and prior art presented in their petition for any subsequent proceedings against this patent, depending on the specifics of the discretionary denial order. For other potential defendants, all prior-art grounds remain available.

There are no apparent pattern signals such as multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner based on the single, non-instituted proceeding. The petitioner, American Airlines, Inc. et al., is a known entity that has been involved in other patent litigation. The fact that the proceeding was a discretionary denial indicates that the PTAB considered external factors, possibly related to ongoing litigation or other efficiency concerns, rather than the patentability arguments themselves.

Recommended next steps

As a defendant facing assertion of this patent:

• Given the discretionary denial of IPR2025-01511, all claims of US7712080 remain formally "untested" by the PTAB. This means there is no FWD to explicitly link to or quote for invalidation.
• The absence of an instituted IPR means the patent owner's claims have not been narrowed at the PTAB. A new IPR challenge could still be considered.
• Carefully review the specific reasoning for the discretionary denial in IPR2025-01511 (if publicly accessible in the E2E file wrapper) to understand the PTAB's rationale and whether it might impact future challenges. This would require accessing the full decision document for IPR2025-01511 on the USPTO PTAB E2E system.
• Consider conducting a new prior art search, as the prior art presented in the denied IPR was not fully evaluated.## Proceedings overview
  One AIA trial proceeding has been filed against US Patent 7,712,080. This proceeding, IPR2025-01511, resulted in a discretionary denial of institution, meaning the claims were not addressed on the merits. This status indicates the patent claims remain untested in AIA trials at the PTAB.

IPR2025-01511 — American Airlines, Inc. et al. v. University of California San Diego

• Type: Inter Partes Review
• Filed: 2025-09-22
• Status: Discretionary Denial (The PTAB declined to institute the IPR based on discretionary grounds, without reaching the merits of the invalidity arguments.)
• Judge panel: The specific judge panel for this proceeding is not publicly available through general web search, particularly as institution was denied.
• Petition grounds: Specific claims challenged, prior art, and statutory bases (§ 102 / § 103 / § 112) are typically detailed in the petition, but the full petition details for IPR2025-01511 are not publicly available in the provided information or general search results for a discretionary denial.
• Institution decision: Denied on 2026-02-27. The PTAB issued a Discretionary Denial. Recent USPTO policy shifts, particularly since early 2025, have expanded the bases for discretionary denials, often relying on factors like parallel district court litigation (Fintiv factors), "settled expectations" (where the patent has been in force for a long time and the petitioner was aware of it), or other workload management considerations, rather than the substantive merits of the invalidity challenge.
• Final Written Decision (if issued): No Final Written Decision was issued as the IPR was not instituted.
• Settlement / termination: The proceeding terminated with the discretionary denial of institution.
• Appeal: No appeal to the Federal Circuit regarding the merits of claim invalidity, as no IPR was instituted. While a discretionary denial itself can be subject to Director Review or, in rare cases, mandamus to the Federal Circuit, no such appeal is indicated in the provided data.
• Defensive value: This proceeding offers no direct defensive value as no claims were invalidated. The discretionary denial means the patent owner successfully fended off this particular challenge without the claims being substantively reviewed, which could be seen as a minor hardening of the patent. This outcome means any assertion of the patent's claims today faces no preclusive effect from this IPR.

Strategic summary

All claims of US Patent 7,712,080 remain UNTESTED by AIA trial proceedings at the PTAB. IPR2025-01511, the sole proceeding filed, was dismissed via a discretionary denial on 2026-02-27 and did not result in any claims being invalidated or sustained on the merits. This leaves the full scope of the original claims intact and subject to future challenges or assertions.

Regarding estoppel, since IPR2025-01511 was denied institution on discretionary grounds, the full scope of § 315(e)(2) estoppel, which typically bars petitioners and their privies from raising grounds that were raised or reasonably could have been raised, is less clear-cut than with a full institution and Final Written Decision. However, the petitioner, American Airlines, Inc. et al., may face some form of estoppel regarding the specific arguments and prior art presented in their petition for any subsequent proceedings against this patent, depending on the specifics of the discretionary denial order. For other potential defendants, all prior-art grounds remain available.

There are no apparent pattern signals such as multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner based on the single, non-instituted proceeding. The petitioner, American Airlines, Inc. et al., is a known entity that has been involved in other patent litigation. The fact that the proceeding was a discretionary denial indicates that the PTAB considered external factors, possibly related to ongoing litigation or other efficiency concerns, rather than the patentability arguments themselves.

Recommended next steps

• Given the discretionary denial of IPR2025-01511, all claims of US7712080 remain formally "untested" by the PTAB. This means there is no FWD to explicitly link to or quote for invalidation.
• The absence of an instituted IPR means the patent owner's claims have not been narrowed at the PTAB. A new IPR challenge could still be considered, but potential petitioners should carefully evaluate the current PTAB landscape regarding discretionary denials, which have become more frequent and policy-driven, particularly since early 2025.
• If you are a defendant, request and carefully review the specific "Discretionary Denial" decision for IPR2025-01511 from the USPTO PTAB E2E system (https://ptab.uspto.gov/#/search/documents) to understand the PTAB's precise rationale. This document would shed light on the grounds for denial, which could influence future defensive strategies.
• Consider conducting a new prior art search, as the prior art presented in the denied IPR was not fully evaluated.